Solid Biosciences Inc. — Director's Dealing 2025

Feb 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-01-31

Reporting Person: Herzich Paul (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-31	Restricted Stock Units	$	A	98700	Acquired		Common Stock (98700)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13889	Direct

Footnotes

F1: Includes 1,707 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 29, 2024.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3: The RSUs were granted on the January 31, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.